AHA forbids Pfizer from presenting torcetrapib results
Pfizer won’t be allowed to present new data on its closely watched developmental drug torcetrapib at the annual American Heart ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.